These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11104240)

  • 1. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Low molecular weight heparin or unfractionated heparin in the treatment of patients with uncomplicated deep vein thrombosis.
    Lane B; Harrison M
    J Accid Emerg Med; 2000 Nov; 17(6):402-3. PubMed ID: 11104240
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Outpatient treatment for patients with uncomplicated above knee deep vein thrombosis.
    Lane B; Harrison M
    J Accid Emerg Med; 2000 Nov; 17(6):403-4. PubMed ID: 11104241
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Subcutaneous heparin is as good as low-molecular-weight heparin in the acute treatment of thrombo-embolic disease.
    Munro A; English C
    Emerg Med J; 2008 May; 25(5):287-9. PubMed ID: 18434466
    [No Abstract]   [Full Text] [Related]  

  • 4. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1. Flight deep vein thrombosis prophylaxis in lower limb injury.
    Blackhurst H
    Emerg Med J; 2009 Apr; 26(4):289. PubMed ID: 19307395
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism.
    Bernardi E; Prandoni P
    Curr Opin Pulm Med; 2005 Sep; 11(5):363-7. PubMed ID: 16093806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Harrington DW; Jindeel A
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227972
    [No Abstract]   [Full Text] [Related]  

  • 7. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Zhan H; Zheng H
    JAMA; 2007 Jan; 297(3):261-2; author reply 263. PubMed ID: 17227970
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Bhala N; Shah A; King A; Molugu C
    JAMA; 2007 Jan; 297(3):261; author reply 263. PubMed ID: 17227971
    [No Abstract]   [Full Text] [Related]  

  • 9. Fixed-dose unfractionated heparin vs low-molecular-weight heparin for venous thromboembolism.
    Edwards JL
    JAMA; 2007 Jan; 297(3):262; author reply 263. PubMed ID: 17227973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L; Naudziūnas A; Unikauskas A
    Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis.
    Coutinho JM; Ferro JM; Canhão P; Barinagarrementeria F; Bousser MG; Stam J;
    Stroke; 2010 Nov; 41(11):2575-80. PubMed ID: 20930161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism.
    Merli GJ
    Am J Phys Med Rehabil; 2000; 79(5 Suppl):S9-16. PubMed ID: 10994898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of deep vein thrombosis in cancer patients.
    Jahanzeb M
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
    [No Abstract]   [Full Text] [Related]  

  • 15. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 16. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep vein thrombosis].
    Moreno-Palomares JJ; Fisac-Herrero RM; Herrero-Domingo A; Ferreira-Pasos EM; Grasa J; Reverte-Cejudo D
    An Med Interna; 2001 Jul; 18(7):364-8. PubMed ID: 11534421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-basis for anticoagulants for cerebral sinus venous thrombosis?
    Cundiff DK
    Stroke; 2013 Jun; 44(6):e67. PubMed ID: 23592764
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to evidence-basis for anticoagulants for cerebral sinus venous thrombosis?
    Coutinho JM; Bousser MG; Stam J
    Stroke; 2013 Jun; 44(6):e68. PubMed ID: 23686970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.